Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Abstract

The cytogenetic PI improves the classification of newly diagnosed patients with MM in the high-risk group compared with current classifications. These findings may facilitate the development of risk-adapted treatment strategies.